Emergency Department Evaluation of Priapism: Etiology and Consultation



Abstract Views
88

Downloads
140

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Apr 30, 2023
Published Aug 31, 2023
10.24018/ejmed.2023.5.4.1789

Abstract viewed = 88 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Introduction: Priapism is a time-critical condition requiring immediate evaluation and management to avoid significant sequela. Management of this condition is significantly variable, dependent upon the underlying cause, and often instituted by a consultant rather than the treating emergency physician.

Objectives: To determine etiologic factors contributing to priapism treatment and determine if treatments initiated in the emergency department (ED) contribute to an improved disposition metric.

Methods: We conducted a multi-center, retrospective study of patients with priapism caused by multiple different etiologies. Study subjected were located at 15 hospitals by chart review and conducted a computer-assisted chart review to locate patients with priapism for each hospital over a 2-year period.

Results: We evaluated 236 patients during the study period; 8 excluded for chart unavailable and 6 with non-priapism diagnosis on review. Median age was 39 years (IQR 22-52). Pediatrics, defined as less than 21 years of age, comprised 4% of patients (N=9). Overall, 85% (N=188) were discharged. Erectile dysfunction medications (EDM) were the most common identifiable cause; involving 23% (N=52). The remaining were sickle cell 20% (N=45), antipsychotic medications 14% (N=30), cocaine 2% (N=4), the remainder without an identifiable etiology. Overall, intrapenile procedures occurred in 56% (N=125) of patients. EDM was associated with significantly less intrapenile procedures compared to other etiologies, 15% (N=58) (p = 0.009), and also had a 2% (N=1) admission rate, significantly less compared to other etiologies (p=0.009). Further, consulting urology did not significantly increase mean length of stay, with difference of 19 minutes (p=0.64) when compared to ED intervention alone.

Conclusion: Priapism as a result of EDM, the most frequent etiology, was associated with less frequent emergent intrapenile procedures and significantly less admissions and urology consultation does not significantly lengthen disposition times.

Keywords: erectile dysfunction injection priapism nonconvulsive status epilepticus, NCSE, epilepsy, status epilepticus, neurology, neuropsychiatry

Downloads

Download data is not yet available.

References

  1. Stein D, Flum A, Cashy J, Zhao L, McVary K. 1138 nationwide emergency department visits for priapism in the United States. J Urol 2013; 187(4S): e461-2.
    DOI  |   Google Scholar
  2. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. American Urological Association guideline on the management of priapism. J Urol. 2003; 170(4 Pt 1): 1318-24.
    DOI  |   Google Scholar
  3. Pyror JP, Hehir M. The management of priapism. J Urol. 1982; 54(6): 751-4.
    DOI  |   Google Scholar
  4. Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000; 95(1): 78-82.
    DOI  |   Google Scholar
  5. Rendon , Livingston M, Suzuki S, Hill W, Walters S. What’s the agreement between self-reported and biochemical verification of drug use? A look at permanent supportive housing residents. Addict Behav. 2017; 70: 90-6.
    DOI  |   Google Scholar
  6. Jam M, Datta NS, Askari A. An unusual case of priapism. J Natl Med Assoc. 1993; 85(6): 473-4.
     Google Scholar
  7. De Luca F, Zacharakis E, Shabbir M, Maurizi A, Manzi E, Zanghì A, et al. Malignant priapism due to penile metastases: Case series and literature review. Arch Ital Urol Androl. 2016; 88(2): 150-2.
    DOI  |   Google Scholar
  8. Dupervil B, Grosse S, Burnett A, Parker C. Emergency department visits and inpatient admissions associated with priapism among males with sickle cell disease in the United States, 2006-2010. PLoS One. 2016; 11(4): e0153257.
    DOI  |   Google Scholar
  9. Emond AM. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980; 140(11): 1434.
    DOI  |   Google Scholar
  10. Hodgson D. Of gods and leeches: treatment of priapism in the nineteenth century. J R Soc Med. 2003; 96(11): 562-5.
    DOI  |   Google Scholar
  11. Levey H, Segal R, Bivalacqua T. Management of Priapism: an update for clinicians. Therapeutic Advances in Urology. 2014.
    DOI  |   Google Scholar
  12. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993; 42(1): 51-3.
    DOI  |   Google Scholar
  13. Nerli RB, Magdum PV, Hiremath SC, Patil AY, Pai SV, Handigund RS, et al. Priapism - A rare presentation in chronic myeloid leukemia: Case report. Urol Case Rep. 2016; 4: 8-10.
    DOI  |   Google Scholar
  14. Olujiohungbe A, Burnett AL. How I manage priapism due to sickle cell disease. Br J Haematol. 2013;160(6):754–65.
    DOI  |   Google Scholar
  15. Rackoff WR, Ohene-Frempong K, Month S, Scott JP, Neahring B, Cohen AR. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr. 1992; 120(6): 882-5.
    DOI  |   Google Scholar
  16. Baverstock RJ, Carey C. Priapism as the presenting complaint in fatal group A streptococcal induced disseminated intravascular coagulation. CJEM. 2018; 20(S2): S6-8.
    DOI  |   Google Scholar
  17. Roghmann F, Becker A, Sammon JD, Ouerghi M, Sun M, Sukumar S, et al. Incidence of priapism in emergency departments in the United States. J Urol. 2013; 190(4): 1275-80.
    DOI  |   Google Scholar
  18. Siddiqua SS, Khan AI, Ahsan K, Pathan FH. Priapism of the newborn - A case report. Mymensingh Med J. 2015; 24(3): 624-7.
     Google Scholar